This article is more than 5 years old. Information may no longer be current.
Oxytocin may improve metabolic control in men with obesity
Among men with obesity, intranasal oxytocin administration led to reduced food intake following an overnight fast vs. men who received an intranasal placebo, according to recent study results.
“We demonstrate that the acute intranasal administration of oxytocin inhibits reward-[driven] but also hunger-driven food intake in obese men and that this effect is not compensated for by changes in energy expenditure,” Manfred Hallschmid, PhD, of the Institute for Medical Psychology and Behavioural Neurobiology at the University of Tubingen, Germany, and colleagues wrote. “In normal-weight men, the oxytocin-induced reduction in calorie consumption was restricted to snacking, indicating that the inhibitory effect of oxytocin on food intake is generally larger in obese than normal-weight subjects.”
Researchers analyzed data from 18 healthy men with obesity and 20 normal-weight men. Each person took part in two experimental sessions 10 days apart following an overnight fast. Participants received either intranasal 24 IU oxytocin (0.6 mL Syntocinon, Defiante Framaceutica) or placebo at 6 individual puffs (3 per alternating nostril) at 30-second intervals. Participants were presented with a free-choice breakfast buffet 45 minutes later; casual snack intake was assessed 95 minutes later under the pretext of a “snack taste test.” Men underwent olfactory function tests and rated feelings of hunger, mood, subjective wellbeing and perceived experimenter’s trustworthiness on visual analogue scales (1-100). Resting energy expenditure and respiratory quotient were measured via indirect calorimetry. Serum insulin, C-peptide cortisol, growth hormone, plasma glucose, lactate, adrenocorticotropic hormone and non-esterified fatty acids were measured.
Researchers found that, among men with obesity, oxytocin reduced overall food consumption from the breakfast buffet by approximately 10% (P < .04 for treatment) vs. placebo, whereas normal-weight men did not alter their breakfast consumption following oxytocin administration. Both men with obesity and normal-weight men receiving oxytocin reduced their total snack intake by 22% (P < .001 for treatment). In both groups, oxytocin administration did not affect resting energy expenditure, but did exert a sustained suppressive effect on postprandial glucose and hypothalamic pituitary adrenal axis secretion. –by Regina Schaffer
Disclosure: The researchers report no relevant financial disclosures.